Chen S - Search Results

1

Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617.

Peng L, Hu Y, Mankowski MC, Ren P, Chen RE, Wei J, Zhao M, Li T, Tripler T, Ye L, Chow RD, Fang Z, Wu C, Dong MB, Cook M, Wang G, Clark P, Nelson B, Klein D, Sutton R, Diamond MS, Wilen CB, Xiong Y, Chen S. Peng L, et al. Among authors: chen re, chen s. bioRxiv [Preprint]. 2021 Dec 24:2021.12.21.473733. doi: 10.1101/2021.12.21.473733. bioRxiv. 2021. PMID: 34981065 Free PMC article. Updated. Preprint.

2

AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma.

Chow RD, Guzman CD, Wang G, Schmidt F, Youngblood MW, Ye L, Errami Y, Dong MB, Martinez MA, Zhang S, Renauer P, Bilguvar K, Gunel M, Sharp PA, Zhang F, Platt RJ, Chen S. Chow RD, et al. Among authors: chen s. Nat Neurosci. 2017 Oct;20(10):1329-1341. doi: 10.1038/nn.4620. Epub 2017 Aug 14. Nat Neurosci. 2017. PMID: 28805815 Free PMC article.

3

Mapping a functional cancer genome atlas of tumor suppressors in mouse liver using AAV-CRISPR-mediated direct in vivo screening.

Wang G, Chow RD, Ye L, Guzman CD, Dai X, Dong MB, Zhang F, Sharp PA, Platt RJ, Chen S. Wang G, et al. Among authors: chen s. Sci Adv. 2018 Feb 28;4(2):eaao5508. doi: 10.1126/sciadv.aao5508. eCollection 2018 Feb. Sci Adv. 2018. PMID: 29503867 Free PMC article.

4

Cancer CRISPR Screens In Vivo.

Chow RD, Chen S. Chow RD, et al. Among authors: chen s. Trends Cancer. 2018 May;4(5):349-358. doi: 10.1016/j.trecan.2018.03.002. Epub 2018 Mar 30. Trends Cancer. 2018. PMID: 29709259 Free PMC article. Review.

5

Programmable sequential mutagenesis by inducible Cpf1 crRNA array inversion.

Chow RD, Kim HR, Chen S. Chow RD, et al. Among authors: chen s. Nat Commun. 2018 May 15;9(1):1903. doi: 10.1038/s41467-018-04158-z. Nat Commun. 2018. PMID: 29765043 Free PMC article.

6

Programmable DNA repair with CRISPRa/i enhanced homology-directed repair efficiency with a single Cas9.

Ye L, Wang C, Hong L, Sun N, Chen D, Chen S, Han F. Ye L, et al. Among authors: chen s, chen d. Cell Discov. 2018 Jul 24;4:46. doi: 10.1038/s41421-018-0049-7. eCollection 2018. Cell Discov. 2018. PMID: 30062046 Free PMC article.

7

Sno-derived RNAs are prevalent molecular markers of cancer immunity.

Chow RD, Chen S. Chow RD, et al. Among authors: chen s. Oncogene. 2018 Dec;37(50):6442-6462. doi: 10.1038/s41388-018-0420-z. Epub 2018 Aug 2. Oncogene. 2018. PMID: 30072739 Free PMC article.

8

Convergent Identification and Interrogation of Tumor-Intrinsic Factors that Modulate Cancer Immunity In Vivo.

Codina A, Renauer PA, Wang G, Chow RD, Park JJ, Ye H, Zhang K, Dong MB, Gassaway B, Ye L, Errami Y, Shen L, Chang A, Jain D, Herbst RS, Bosenberg M, Rinehart J, Fan R, Chen S. Codina A, et al. Among authors: chen s. Cell Syst. 2019 Feb 27;8(2):136-151.e7. doi: 10.1016/j.cels.2019.01.004. Epub 2019 Feb 20. Cell Syst. 2019. PMID: 30797773 Free PMC article.

9

In vivo profiling of metastatic double knockouts through CRISPR-Cpf1 screens.

Chow RD, Wang G, Ye L, Codina A, Kim HR, Shen L, Dong MB, Errami Y, Chen S. Chow RD, et al. Among authors: chen s. Nat Methods. 2019 May;16(5):405-408. doi: 10.1038/s41592-019-0371-5. Epub 2019 Apr 8. Nat Methods. 2019. PMID: 30962622 Free PMC article.

10

Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells.

Dong MB, Wang G, Chow RD, Ye L, Zhu L, Dai X, Park JJ, Kim HR, Errami Y, Guzman CD, Zhou X, Chen KY, Renauer PA, Du Y, Shen J, Lam SZ, Zhou JJ, Lannin DR, Herbst RS, Chen S. Dong MB, et al. Among authors: chen ky, chen s. Cell. 2019 Aug 22;178(5):1189-1204.e23. doi: 10.1016/j.cell.2019.07.044. Cell. 2019. PMID: 31442407 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

81,573 results

Search Page